Literature DB >> 33575783

Prevalence of Memory-Related Diagnoses Among U.S. Older Adults With Early Symptoms of Cognitive Impairment.

Yuting Qian1, Xi Chen2, Diwen Tang3, Amy S Kelley4,5, Jing Li1.   

Abstract

BACKGROUND: Early diagnosis of cognitive impairment may confer important advantages. Yet the prevalence of memory-related diagnoses among older adults with early symptoms of cognitive impairment is unknown.
METHODS: A retrospective, longitudinal cohort design using 2000-2014 Health and Retirement Survey-Medicare linked data. We leveraged within-individual variation to examine the relationship between incident cognitive impairment and receipt of diagnosis among 1225 individuals aged 66 or older. Receipt of a memory-related diagnosis was determined by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Incident cognitive impairment was defined as the first assessment wherein the participant's modified Telephone Interview for Cognitive Status score was less than 12.
RESULTS: The unadjusted prevalence of memory-related diagnosis at cognitive impairment was 12.0%. Incident cognitive impairment was associated with a 7.3% (95% confidence interval [CI], 5.6% to 9.0%; p < .001) higher adjusted probability of any memory-related diagnosis overall, yielding 9.8% adjusted prevalence of diagnosis. The increase in likelihood of diagnosis associated with cognitive decline was significantly higher among non-Hispanic Whites than non-Hispanic Blacks (8.2% vs -0.7%), and among those with at least a college degree than those with a high school diploma or less (17.4% vs 6.8% vs 1.6%). Those who were younger, had below-median wealth, or without a partner had lower probability of diagnosis than their counterparts.
CONCLUSIONS: We found overall low prevalence of early diagnosis, or high rate of underdiagnosis, among older adults showing symptoms of cognitive impairment, especially among non-Whites and socioeconomically disadvantaged subgroups. Our findings call for targeted interventions to improve the rate of early diagnosis, especially among vulnerable populations.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CIND; Cognitive decline; Cognitive impairment; Dementia; Memory-related diagnosis

Mesh:

Year:  2021        PMID: 33575783      PMCID: PMC8436977          DOI: 10.1093/gerona/glab043

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  29 in total

1.  Self-administered Gerocognitive Examination (SAGE): a brief cognitive assessment Instrument for mild cognitive impairment (MCI) and early dementia.

Authors:  Douglas W Scharre; Shu-Ing Chang; Robert A Murden; James Lamb; David Q Beversdorf; Maria Kataki; Haikady N Nagaraja; Robert A Bornstein
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

2.  Community Cognitive Screening Using the Self-Administered Gerocognitive Examination (SAGE).

Authors:  Douglas W Scharre; Shu Ing Chang; Haikady N Nagaraja; Jennifer Yager-Schweller; Robert A Murden
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

Review 3.  Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease.

Authors:  Alexander L Chin; Selamawit Negash; Roy Hamilton
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

4.  Knowledge of Alzheimer's disease in four ethnic groups of older adults.

Authors:  Liat Ayalon; Patricia A Areán
Journal:  Int J Geriatr Psychiatry       Date:  2004-01       Impact factor: 3.485

5.  Racial differences in knowledge and beliefs about Alzheimer disease.

Authors:  Cathleen M Connell; J Scott Roberts; Sara J McLaughlin; Dapo Akinleye
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

6.  Dementia assessment in primary care: results from a study in three managed care systems.

Authors:  Linda Boise; Margaret B Neal; Jeffrey Kaye
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-06       Impact factor: 6.053

7.  Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.

Authors:  Perminder S Sachdev; Darren M Lipnicki; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Wei Wen; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

Review 8.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

9.  Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data.

Authors:  Yi Chen; Bryan Tysinger; Eileen Crimmins; Julie M Zissimopoulos
Journal:  Alzheimers Dement (N Y)       Date:  2019-06-06

10.  Comparison of Methods for Algorithmic Classification of Dementia Status in the Health and Retirement Study.

Authors:  Kan Z Gianattasio; Qiong Wu; M Maria Glymour; Melinda C Power
Journal:  Epidemiology       Date:  2019-03       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.